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Abstract
Background—Current US colorectal cancer screening guidelines that call for shared decision 
making regarding the choice among several recommended screening options are difficult to 
implement. Multi-criteria decision analysis (MCDA) is an established methodology well suited for 
supporting shared decision making. Our study goal was to determine if a streamlined form of 
MCDA using rank order based judgments can accurately assess patients’ colorectal cancer 
screening priorities.
Methods—We converted priorities for four decision criteria and three sub-criteria regarding 
colorectal cancer screening obtained from 484 average risk patients using the Analytic Hierarchy 
Process (AHP) in a prior study into rank order-based priorities using rank order centroids. We 
compared the two sets of priorities using Spearman rank correlation and non-parametric Bland-
Altman limits of agreement analysis. We assessed the differential impact of using the rank order-
based versus the AHP-based priorities on the results of a full MCDA comparing three currently 
recommended colorectal cancer screening strategies. Generalizability of the results was assessed 
using Monte Carlo simulation.
Results—Correlations between the two sets of priorities for the seven criteria ranged from 0.55 
to 0.92. The proportions of absolute differences between rank order-based and AHP-based 
priorities that were more than ± 0.15 ranged from 1% to 16%. Differences in the full MCDA 
results were minimal and the relative rankings of the three screening options were identical more 
than 88% of the time. The Monte Carlo simulation results were similar.
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Conclusion—Rank order-based MCDA could be a simple, practical way to guide individual 
decisions and assess population decision priorities regarding colorectal cancer screening strategies. 
Additional research is warranted to further explore the use of these methods for promoting shared 
decision making.
Background
Current US guidelines call for screening patients at average risk for colorectal cancer with 
one of up to six options that differ across multiple dimensions. They recommend that 
screening decisions be made through a shared decision making process that incorporates 
individual patient preferences and values. [1, 2]
Shared decision making differs from conventional patient education and clinical decision 
making activities in its emphasis on engaging patients and integrating their preferences into 
clinical decisions. Evidence exists suggesting that shared decision making is associated with 
both improved health care quality and reduced healthcare costs. [3–5] Although the 
principles of shared decision making apply to many healthcare decisions, they are 
particularly important in preference-sensitive situations, like colorectal cancer screening for 
average risk patients, where no clearly dominant strategy exists. [6]
Patient decision aids, developed to facilitate shared decision making, have been shown to 
increase patients’ knowledge, reduce decisional conflict, and foster patient involvement in 
decisions about their care but are difficult to implement in a busy practice. [7] Commonly 
identified implementation barriers include lack of time, inadequate provider expertise, and 
care systems that discourage their adoption. [4, 8] Successful dissemination of shared 
decision making therefore depends on the development of tools, processes, and systems of 
care that will make shared decision making feasible within the constraints imposed by 
clinical settings.
Tools that could effectively catalyze this process already exist. Multi-criteria decision 
analysis (MCDA) provides decision makers with a logical, structured, and transparent 
approach for eliciting decision-related preferences and integrating them into the decision 
making process. We and others have shown that they can be applied to clinical decisions, are 
well accepted by patients, and can foster effective doctor-patient communication. [9–13] A 
variety of multi-criteria methods are available that range from simple, a-theoretical 
assessments to sophisticated, theory-based procedures. [14, 15] Although methods in the 
latter category could be expected to provide more valid and reliable information, they 
typically are more complicated and require significantly more time and effort. Consequently 
they are more difficult to implement and may result in higher rates of user errors that can 
limit or even negate their effectiveness. [16]
For these reasons, there has been increasing interest in the development of easier to use 
methods that still provide decision makers with the benefits of a multi-criteria analysis. 
Rank ordering, which only involves ranking decision criteria from most to least important, is 
the simplest assessment procedure. Methods based on rank ordering have received 
considerable attention and have been recommended for general use. [16–19]
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The procedural simplicity of rank order MCDA combined with the close correspondence 
between the MCDA framework and the requirements of shared decision making suggest that 
it could be a useful way to implement shared decision making in busy practice settings. The 
first step in exploring this hypothesis is to determine if rank order MCDA can accurately 
assess patient decision priorities. To date, studies examining the accuracy of rank order 
methods have relied on simulations to determine a “correct” decision that is then used as the 
reference standard for comparison. [20–22] The ability of these methods to accurately assess 
healthcare decision priorities of patients is unknown. To address this question, we compared 
patient rank order-based decision priorities regarding the choice of a colorectal cancer 
screening program with priorities obtained using the analytic hierarchy process (AHP), a 
widely used, theoretically grounded MCDA method.
Methods
Brief summary of the original study
To determine how people at average risk for colorectal cancer view the advantages and 
disadvantages of alternative screening strategies, we used the Analytic Hierarchy Process 
(AHP) to assess decision priorities of people at average risk for colorectal cancer in a multi-
center study. The AHP is a widely used, theory-based multi-criteria method that derives 
decision priorities from a series of pairwise comparisons. A description of the AHP is 
beyond the scope of this report. Full details are available elsewhere. [15, 23–27]
After a brief introduction, study participants performed a full AHP analysis using the four 
major decision criteria and three sub-criteria shown in Figure 1 to compare colorectal cancer 
screening options. A standard AHP-assessment procedure was used for the study that 
instructed participants to first rank order the criteria in order of importance, and then 
perform the pairwise comparisons needed to calculate the AHP priorities. [28] Full details 
and study results have been published. [11]
Calculation of rank order-based priorities
The use of rank order centroids to create priority weights for decision criteria was first 
proposed by Barron and Hutton and incorporated in a MCDA method called SMARTER 
(Simple Multi-attribute Rating Technique Exploiting Ranks). [16] Subsequent research has 
found this approach to be the most accurate of several alternative methods for converting 
rank order decision criteria priorities into priority weights. [20–22] Rank order centroids are 
calculated using the formula:
Where i= 1,2,…n, k is the rank order for each criterion, w is the rank order centroid priority 
weight of rank k, and n is the number of criteria. For example:
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Table 1 shows rank order centroid weights for sets of 3 and 4 items.
For this study we derived rank order-based priorities for the decision criteria and sub-criteria 
from the AHP-based priority scores generated by the participants in the previous study. We 
first ordered the AHP-based priority scores from best to worst and then assigned the rank 
order weight associated with each ranking. If ties existed, we averaged the rank order 
weights of the adjacent ranks. [18] An example of this conversion using one of the study 
participant’s priorities is shown in Table 1.
Decision Priority Comparison Method
We compared the absolute differences between the original AHP-based decision criteria 
priority weights generated by the 484 participants in the previous study (the standard 
measure) with the derived rank order-based priorities (the experimental measure) by 
subtracting the rank order-based priority from the original AHP-based priority for each 
study participant. Both sets of priorities are measured on a 0–1 scale with 0 indicating no 
influence on the decision and 1 indicating absolute influence. Because the measurement 
differences are not normally distributed, we examined the relationship between the two sets 
of priorities using Spearman rank order correlation analysis. To examine the extent to which 
the two measures differ, we used the non-parametric form of Bland-Altman limits of 
agreement analysis. The Bland-Altman method is currently the standard approach for 
comparing two measurement methods but assumes that the differences in measurement 
values being examined are normally distributed. [29, 30] The non-parametric version 
involves calculating the proportion of measurements that fall within a defined interval, 
chosen based on clinically important differences, rather than calculated 95% confidence 
limits used in the standard Bland-Altman procedure. [31]
We calculated the differences between the two sets of priorities using the formula AHP-
based – rank order-based priority and tallied the frequency of differences that were greater 
than ± 0.10, and ± 0.15 of the AHP-based value which we tentatively defined as possible 
and probable clinically important discrepancies. We then summarized the results using a 
discordance proportion plot, which illustrates the percentage of measurements that fall 
within various limits using a modified Kaplan-Meier survival analysis with the absolute 
difference between the two measures used in place of the more usual survival time. [32]
Decision comparison method
To further determine the significance of differences between the two sets of decision 
priorities, we compared the results of using them in a full multi-criteria decision analysis 
comparing the three screening options currently recommended by the US Preventive Service 
Task Force for average risk patients aged 50 to 75 years: colonoscopy every 10 years, 
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annual immunochemical fecal occult blood tests, and immunochemical fecal occult blood 
tests every three years combined with flexible sigmoidoscopy every 5 years. [1]
The results of a multi-criteria analysis are a function of both the criteria decision priorities 
and assessments regarding how well the decision options meet the criteria. We therefore 
used a standard set of option assessments to isolate the effects of the differences between the 
AHP-based and rank order-based priorities on the results. We used the estimated outcomes 
for 50 year old patients used in the original study to compare the three screening options 
with regard to preventing cancer, minimizing serious side effects, and avoiding false 
positive screening tests. (These data are included in an online supplemental file: 
“Information about the screening options used for analysis for 50 year old patients”.) To 
assess cancer prevention, we created a normalized score by dividing each option’s estimated 
number of prevented cancers by the sum of all three options. We followed the same 
procedure for minimizing side effects and avoiding false positives except we used the 
reciprocals of the outcome estimates because better programs minimize rather than 
maximize these criteria. Because there is no objective way to measure how well the 
screening options meet the three logistical sub-criteria, we used the mean responses obtained 
from the participants in the original study. The resulting standard set of screening option 
assessments is shown in Table 2.
We then calculated AHP-based and rank order-based overall scores for the three screening 
options for each study participant by multiplying the option assessments by the priorities 
assigned to each criterion and summing the results using the following formula:
where pk represents the priority assigned to criterion k, ok represents the score describing 
how well option o meets criterion k, and n equals the number of criteria.
We measured the differential effects of the two sets of priorities by comparing the rank order 
of the decision options and the differences between the overall option scores generated using 
the two sets of priorities.
Generalizability analysis
To estimate the generalizability of the findings from the study data, we conducted a Monte 
Carlo simulation. We first created AHP comparison matrices consisting of three and four 
rank-ordered criteria. For each matrix, each pairwise comparison entry consisted of a 
variable constrained to maintain the original rank order of the two criteria involved in the 
comparison. For example, in the four criteria matrix the variable representing the 
comparison between the 3rd and 4th ranked criteria, 3vs4, was input into the simulation as a 
variable with a uniform distribution varying from 0.1 (indicating that the 3rd criterion was 
minimally preferable to the 4th) to 8.8. The variable representing the comparison between 
the 2nd and 4th ranked criteria, 2vs4, was then input as a uniform distribution ranging from 
(3vs4 + 0.1) to 8.9. The variable representing the comparison between the 1st and 4th ranked 
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criteria, 1vs4, was then input as a uniform distribution ranging from (2vs4 + 0.1) to 9. (The 
reductions in the full 1–9 conventional AHP pairwise comparison scale were made to 
simplify the simulation and are very unlikely to affect the results significantly.) The rest of 
the comparisons needed to complete the comparison matrix were created similarly. We 
chose to use uniform distributions for all variables to simulate the entire range of possible 
pairwise comparison matrices.
Ten thousand iterations were run. Simulation outputs included the criteria priorities derived 
from the AHP comparison matrix calculated using the geometric mean method [28, 33], 
differences between the simulated AHP-based priorities and the fixed rank order based-
priorities, and the number of times the AHP-based and rank order-based criteria priorities 
resulted in differences in the rankings assigned to the three recommended CRC screening 
strategies described earlier using the most common rank ordering of criteria in the data set: 
Prevent Cancer > Avoid Side Effects > Minimize False Positives > Logistics and Procedure 
> Preparation > Frequency.
All statistical analyses were performed using MEDCALC. [34] The Monte Carlo simulation 
was performed using @Risk 6.0. [35]
Results
Description of the study population
The study sample consists of 484 patients at average risk for colorectal cancer. Their 
demographic characteristics are summarized in Table 3. Their mean age was approximately 
62 years, 65% were female, 49% were black, and 42% were white.
Comparisons between AHP and Rank order priorities
The relationship between the two sets of priorities is illustrated in Figure 2. The biggest 
difference is the fixed nature of the values associated with the rank order-based priorities 
versus the more continuous AHP-based priorities. It is also apparent that the differences 
between the two are more pronounced at higher priorities.
The differences between the AHP-based colorectal cancer decision priorities and the derived 
rank order-based priorities are summarized in Table 4. Absolute differences in mean 
priorities range from 0.01 to 0.07. The differences in individual priorities are illustrated in 
Figures 3 and 4 and summarized in a supplemental file “Non-parametric analysis results”. 
The percentage of differences within ± 0.10 ranged from 70% to 95%, and the percentage of 
differences within ± 0.15 ranged from 84% to 99%. Based on our proposed classification 
system, these results indicate that at least some of the differences in criteria decision 
priorities are probably clinically significant. Spearman’s coefficients of rank correlation are 
0.86 or higher except for Prevent Cancer, which has a correlation coefficient of 0.55
Comparisons between AHP-based and Rank order-based decision analyses
The results of the decision analyses using the two sets of decision criteria priorities are 
summarized in Table 5. The relative rankings of the three screening options were the same 
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more than 88% of the time and there were only minimal differences between the AHP-based 
and rank order-based scores.
Generalizability analysis
The differences between the simulated AHP priority values and the fixed rank order values 
for comparisons involving 3 and 4 criteria are shown in Table 6. For both sets of 
comparisons, the rank order priority weights tend to underestimate the AHP-based weight of 
the top ranked priority and overestimate the AHP-based weights of all others. Despite these 
differences, as shown in Table 5, the full multi-criteria analysis of the three standard 
colorectal cancer screening options using the AHP-based and rank order-based criteria 
priorities yielded the identical rank orderings 90.1% of the time for two screening options - 
colonoscopy every 10 years and annual immunochemical fecal occult blood tests every three 
years combined with flexible sigmoidoscopy every 5 years - and 99% of the time for the 
third: annual immunochemical fecal occult blood tests.
Discussion
In absolute terms, the extent of agreement between the rank order-based and AHP-based 
decision priorities in this study varied from excellent to fair. The mean priorities were 
almost identical for all the decision criteria but the congruence between participants’ 
individual priorities was more variable. The biggest difference in individual priorities 
occurred relative to the criterion Prevent Cancer, where the correlation between the two sets 
of priorities was 0.55, 28% of the differences were greater than ± 0.10, and 15% were 
greater than ± 0.15. Discrepancies were also found among priorities assigned to the two of 
the three logistical sub-criteria. Although highly correlated, 14% of the measurements for 
Screening Frequency and 16% of the measurements for Screening Procedure disagreed by 
more than ± 0.15. These results indicate that, in this dataset, the rank order-based priorities 
are good approximations of group mean decision criteria priorities regarding colorectal 
cancer screening but less accurate at the individual level.
The importance of the differences in individual priorities depends on the clinical context and 
the adequacy of alternative methods for implementing shared decision making in practice. 
Despite the variance in criteria priorities, the results of full multi-criteria analyses using 
individual rank order-based and AHP-based priorities using both the study data and 
simulation data were the same at least 88% of the time. Moreover, since the purpose of the 
rank based MCDA is to promote shared decision making, rather than prescribe a specific 
course of action, the primary objective is to assess patient and provider decision priorities 
and identify differences in need of further discussion. The relative magnitude of the 
differences therefore becomes less important than being able to assess them quickly, easily, 
and transparently. Multiple studies have found that patient and provider preferences for 
colorectal cancer screening frequently differ and we currently do not have the tools needed 
to adequately implement shared decision making in practice. [36–44] From this perspective 
our findings suggest that simple rank order-based methods could provide a clinically 
feasible method for eliciting patient preferences regarding colorectal cancer screening 
options and incorporating them into a shared clinical decision making process.
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Our results are consistent with several prior studies that have found good agreement between 
rank order-based priorities and decision quality. These studies have all defined quality 
decisions using “hit rates” of different weighting methods, i.e., the proportion of correct 
decisions identified using simulated cases as the reference standard. Reported hit rates for 
rank order-based priorities are approximately 85%, quite consistent with our results. [20–22] 
To our knowledge, this is the first study to assess both the accuracy of rank order-based 
decision priorities obtained from a sample of real decision stakeholders with those obtained 
using a more conventional MCDA priority assessment method and the impact of using them 
in a multi-criteria decision analysis of a clinical decision.
A key assumption in our analysis is the appropriateness of using the AHP-derived weights to 
define the study participants’ “true” decision priorities. We believe that this approach is well 
supported by previous research. Decision priorities generated using the AHP pairwise 
comparison process have been extensively validated and determined to be quite accurate 
when compared with measurable physical properties and forecasted future events. [45] They 
have also been shown to accurately reflect subjective preferences and enhance the decision 
making process. [46]
This study is subject to several limitations. The first is that the results were obtained from a 
single study sample using one particular implementation of a sole MCDA method. Therefore 
the results may not be generalizable to other populations or decision making situations. They 
do, however, adequately represent differences in priorities within the context of the original 
study and are consistent with the results of our simulated generalizability analysis. It is also 
possible that variations in how the study participants performed their AHP analyses could 
have affected the results. To explore this possibility we repeated the analysis using only the 
379 participants who met a common standard for a technically adequate AHP analysis as 
described in our earlier paper and found similar results. (Data not reported) Another possible 
limitation is the definitions used to identify possible and probable clinically important 
discrepancies in the Bland-Altman analysis. These tentative definitions were needed because 
standard measures are not available. Although they worked well in the current study, they 
may not be as applicable in other contexts. We also used only one set of decision option 
assessments to compare the impact of the two sets of priorities on a full multi-criteria 
decision analysis. As noted above, we used a standard set of option assessments in order to 
focus our analysis on the impact of the different priorities. Because of the interrelationship 
between criteria priorities and option assessments in MCDA, it is possible that the 
differences between the two sets of criteria priorities would have a greater impact on the 
results if they were combined with different sets of option assessments. Finally, because 
they were beyond the scope of the current analysis, we did not determine if the use of either 
of these two priority assessment methods would result in better colorectal cancer screening 
decisions than those that are currently made or examine if they facilitate and foster use of 
shared decision making in practice.
Despite these limitations, the results of this study suggest that the use of rank order-based 
decision priorities in lieu of more precisely determined priorities obtained using the AHP or 
an alternative MCDA method could be a simple, practical way to both guide individual 
decisions and assess population criteria priorities regarding colorectal cancer screening. 
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Additional research is warranted to determine if rank order-based methods can be used to 
facilitate shared decision making regarding colorectal cancer screening in practice and to 
further explore the advantages and disadvantages of simpler versus more rigorous MCDA 
methods for assessing individual and aggregate patient preferences and incorporating them 
into additional preference-sensitive healthcare decisions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
The decision model.
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Figure 2. 
Example of the relationship between AHP and rank order based decision priorities
Dolan et al. Page 13
Med Decis Making. Author manuscript; available in PMC 2015 June 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Discordance-proportion plot, major decision criteria priorities
The discordance proportion refers to the proportion of differences that equal or exceed the 
value on the x-axis. More concordant measurements will have curves farther to the left of 
this graph. More discordant measures will have curves farther to the right.
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Figure 4. Discordance-proportion plot, logistical sub-criteria
The discordance proportion refers to the proportion of differences that equal or exceed the 
value on the x-axis. More concordant measurements will have curves farther to the left of 
this graph. More discordant measures will have curves farther to the right.
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Table 3
Description of the study population, n = 484
Parameter Number (percent)
Gender
Male 166 (34%)
Female 315 (65%)
Missing 3 (1%)
Age
50–54 87 (18%)
55–59 86 (18%)
60–64 88 (18%)
65–69 88 (18%)
70–74 54 (11%)
75–79 44 (9%)
80–84 37 (8%)
Missing 0
Race
African-American 238 (49%)
American Indian 1 (0.2%)
Asian 2 (0.4%)
White 202 (42%)
Missing or Other 41 (9%)
Ethnicity
Non-Hispanic 405 (91%)
Hispanic 3 (0.7%)
Missing or Other 76 (8%)
Education
< 7 years 2 (0.4%)
Junior high school 24 ( 5%)
Partial high school 54 (11%)
High school 152 (31%)
Partial college 121 (25%)
College 64 (13%)
Graduate 60 (12%)
Missing 7 (1%)
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